416 related articles for article (PubMed ID: 24356194)
1. Drug therapy in stroke: from preclinical to clinical studies.
Kaur H; Prakash A; Medhi B
Pharmacology; 2013; 92(5-6):324-34. PubMed ID: 24356194
[TBL] [Abstract][Full Text] [Related]
2. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
3. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
[TBL] [Abstract][Full Text] [Related]
4. Advances in stroke pharmacology.
Zhou Z; Lu J; Liu WW; Manaenko A; Hou X; Mei Q; Huang JL; Tang J; Zhang JH; Yao H; Hu Q
Pharmacol Ther; 2018 Nov; 191():23-42. PubMed ID: 29807056
[TBL] [Abstract][Full Text] [Related]
5. Targets of cytoprotection in acute ischemic stroke: present and future.
Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
[TBL] [Abstract][Full Text] [Related]
6. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
Schmidt A; Minnerup J; Kleinschnitz C
Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
[TBL] [Abstract][Full Text] [Related]
7. The ischemic penumbra: a new opportunity for neuroprotection.
Fisher M
Cerebrovasc Dis; 2006; 21 Suppl 2():64-70. PubMed ID: 16651816
[TBL] [Abstract][Full Text] [Related]
8. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
Barone FC
Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection for ischaemic stroke: current status and challenges.
Moretti A; Ferrari F; Villa RF
Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on neuroprotective stroke therapy.
Schäbitz WR; Fisher M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
[TBL] [Abstract][Full Text] [Related]
11. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.
Timsit S; Menn B
Clin Pharmacol Ther; 2012 Feb; 91(2):327-32. PubMed ID: 22218073
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
[TBL] [Abstract][Full Text] [Related]
14. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
Saver JL
Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
[TBL] [Abstract][Full Text] [Related]
15. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
Köhrmann M; Schellinger PD; Schwab S
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review.
Dhir N; Medhi B; Prakash A; Goyal MK; Modi M; Mohindra S
Curr Neuropharmacol; 2020; 18(7):596-612. PubMed ID: 31934841
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
Davis M; Barer D
Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
[TBL] [Abstract][Full Text] [Related]
18. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?
Gibson CL; Coomber B; Rathbone J
Neuroscientist; 2009 Aug; 15(4):324-32. PubMed ID: 19359672
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch.
Chavez JC; Hurko O; Barone FC; Feuerstein GZ
Stroke; 2009 Oct; 40(10):e558-63. PubMed ID: 19745180
[TBL] [Abstract][Full Text] [Related]
20. Advanced neuroprotection for brain ischemia: an alternative approach to minimize stroke damage.
Ayuso MI; Montaner J
Expert Opin Investig Drugs; 2015; 24(9):1137-42. PubMed ID: 26138255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
